Puma Biotechnology, Inc. (PBYI)
10.25
+0.42
(+4.27%)
USD |
NASDAQ |
Oct 19, 14:43
Puma Biotechnology Cash from Operations (Annual) : 41.80M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 41.80M |
| December 31, 2024 | 38.92M |
| December 31, 2023 | 27.01M |
| December 31, 2022 | -15.83M |
| December 31, 2021 | 20.65M |
| December 31, 2020 | 0.773M |
| December 31, 2019 | 22.38M |
| December 31, 2018 | -24.10M |
| Date | Value |
|---|---|
| December 31, 2017 | -172.47M |
| December 31, 2016 | -141.69M |
| December 31, 2015 | -154.47M |
| December 31, 2014 | -77.20M |
| December 31, 2013 | -55.05M |
| December 31, 2012 | -44.01M |
| December 31, 2011 | -1.825M |
| December 31, 2010 | -0.0182M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anika Therapeutics, Inc. | 11.19M |
| Arcutis Biotherapeutics, Inc. | -5.625M |
| Olema Pharmaceuticals, Inc. | -146.72M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |